Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

RACK1: a novel substrate for the Src protein-tyrosine kinase

An Erratum to this article was published on 18 March 2003

Abstract

RACK1 is one of a group of PKC-interacting proteins collectively called RACKs (Receptors for Activated C-Kinases). Previously, we showed that RACK1 also interacts with the Src tyrosine kinase, and is an inhibitor of Src activity and cell growth. PKC activation induces the intracellular movement and co-localization of RACK1 and Src, and the tyrosine phosphorylation of RACK1. To determine whether RACK1 is a Src substrate, we assessed phosphorylation of RACK1 by various tyrosine kinases in vitro, and by kinase-active and inactive mutants of Src in vivo. We found that RACK1 is a Src substrate. Moreover, Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src's SH2 domain that occur following PKC activation. To identify the tyrosine(s) on RACK1 that is phosphorylated by Src, we generated and tested a series of RACK1 mutants. We found that Src phosphorylates RACK1 on Tyr 228 and/or Tyr 246, highly-conserved tyrosines located in the sixth WD repeat that interact with Src's SH2 domain. We think that RACK1 is an important Src substrate that signals downstream of growth factor receptor tyrosine kinases and is involved in the regulation of Src function and cell growth.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 6
Figure 5
Figure 7

Similar content being viewed by others

References

  • Abram CL, Courtneidge SA . 2000 Exp. Cell. Res. 254: 1–13

  • Bjorge JD, Jakymiw A, Fujita DJ . 2000 Oncogene 19: 5620–5635

  • Cartwright CA, Eckhart W, Simon S, Kaplan PL . 1987 Cell 49: 83–91

  • Cartwright CA, Hutchinson M, Eckhart W . 1985 Mol. Cell. Biol. 5: 2647–2652

  • Cartwright CA, Kaplan PL, Cooper JA, Hunter T, Eckhart W . 1986 Mol. Cell. Biol. 6: 1562–1570

  • Cartwright CA, Meisler MA, Eckhart W . 1990 Proc. Natl. Acad. Sci. USA 87: 558–562

  • Chang BY, Chiang M, Cartwright CA . 2001 J. Biol. Chem. 276: 20346–20356

  • Chang BY, Conroy KB, Machleder EM, Cartwright CA . 1998 Mol. Cell. Biol. 18: 3245–3256

  • Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R . 1995 Nature 377: 548–552

  • Glenny JR, Zokas L, Kamps MP . 1988 J. Imm. Meth. 109: 277–285

  • Kmiecik TE, Shalloway D . 1987 Cell 49: 65–73

  • Lipsich LA, Lewis AJ, Brugge JS . 1983 J. Virol. 48: 352–360

  • Lou Q, Leftwich ME, Lam KS . 1996 Bioorg. Med. Chem. 4: 677–682

  • Martin GS . 2001 Nature Rev. Mol. Cell Biol. 2: 467–475

  • Mayer BJ, Hirai H, Sakai R . 1995 Curr. Biol. 5: 296–305

  • Mochly-Rosen D, Kauvar LM . 1998 Adv. Pharm. 44: 91–145

  • Mochly-Rosen D . 1995 Science 268: 247–251

  • Mourton T, Hellberg CB, Burden-Gulley SM, Hinman J, Rhee A, Brady-Kalnay SM . 2001 J. Biol. Chem. 276: 14896–14901

  • Moyers JS, Bouton AB, Parsons SJ . 1993 Mol. Cell. Biol. 13: 2391–2400

  • Neer EJ, Smith TF . 1996 Cell 84: 175–178

  • Neer EJ, Schmidt CJ, Nambudripad R, Smith TF . 1994 Nature 371: 297–300

  • Park J, Cartwright CA . 1995 Mol. Cell. Biol. 15: 2374–2382

  • Pellicena P, Stowell KR, Miller WT . 1998 J. Biol. Chem. 273: 15325–15328

  • Piwnica-Worms H, Saunders KB, Roberts TM, Smith AE, Cheng SH . 1987 Cell 49: 75–82

  • Reynolds AB, Vila J, Lansing TJ, Potts WM, Weber MJ, Parsons JT . 1987 EMBO J. 6: 2359–2364

  • Schechtman D, Mochly-Rosen D . 2001 Oncogene 20: 6339–6347

  • Schmitz R, Baumann G, Gram H . 1996 J. Mol. Biol. 260: 664–677

  • Snyder MA, Bishop JM, McGrath JP, Levinson AD . 1985 Mol. Cell. Biol. 5: 1772–1779

  • Thomas SM, Brugge JA . 1997 Annu. Rev. Cell Dev. Biol. 13: 513–609

  • Zhou S, Caraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadl M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo ML, Ponder BAJ, Mayer BJ, Cantley LC . 1995 Nature 373: 536–544

Download references

Acknowledgements

We thank David Shalloway for NIH3T3 cell lines expressing v-Src or c-Src mutants Y527F, Y527F/Y416F or Y416F. We are grateful to Jean Wang for purified Abl kinase, Sarah Parsons for pMdl155c-src and Tony Hunter for pGEM K297M. We thank Daria Mochly-Rosen, Anson Lowe and Bishr Omary for critical review of the data. We are grateful to Blanca Pineda for assistance with preparation of the manuscript and figures. This work was supported by grants from the National Institutes of Health to CA Cartwright (R01 DK43743) and to BY Chang (National Research Service Award CA69810).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine A Cartwright.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, B., Harte, R. & Cartwright, C. RACK1: a novel substrate for the Src protein-tyrosine kinase. Oncogene 21, 7619–7629 (2002). https://doi.org/10.1038/sj.onc.1206002

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206002

Keywords

This article is cited by

Search

Quick links